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Osteosarcoma (OS) is the most common primary malignancy of bone, and pulmonary
metastatic disease accounts for nearly all mortality. However, little is known about the bio-
chemical signaling alterations that drive the progression of metastatic disease.Two murine
OS cell populations, K7M2 and K12, are clonally related but differ significantly in their
metastatic phenotypes and therefore represent excellent tools for studying metastatic OS
molecular biology. K7M2 cells are highly metastatic, whereas K12 cells display limited
metastatic potential. Here we report that the expression of Notch genes (Notch1, 2, 4)
are up-regulated, including downstream targets Hes1 and Stat3, in the highly metastatic
K7M2 cells compared to the less metastatic K12 cells, indicating that the Notch signal-
ing pathway is more active in K7M2 cells. We have previously described that K7M2 cells
exhibit higher levels of aldehyde dehydrogenase (ALDH) activity. Here we report that K7M2
cell ALDH activity is reduced with Notch inhibition, suggesting that ALDH activity may be
regulated in part by the Notch pathway. Notch signaling is also associated with increased
resistance to oxidative stress, migration, invasion, and VEGF expression in vitro. However,
Notch inhibition did not significantly alter K7M2 cell proliferation. In conclusion, we provide
evidence that Notch signaling is associated with ALDH activity and increased metastatic
behavior in OS cells. Both Notch and ALDH are putative molecular targets for the treatment
and prevention of OS metastasis.
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INTRODUCTION
Osteosarcoma (OS), the most common primary malignancy of
bone, usually occurs in the long bones of youths in the first and
second decades of life (Bielack et al., 2002; Carrle and Bielack,
2006; Hayden and Hoang, 2006). Despite pre- and post-operative
chemotherapy with wide surgical resection of the tumor, overall
survival for patients with OS is only 65–70% (Bielack et al., 2002;
Ferrari et al., 2005; Carrle and Bielack, 2006; Meyers et al., 2008;
Messerschmitt et al., 2009). The presence of metastatic disease at
the time of diagnosis is clinically detectable in one out of every
five cases, and portends a particularly poor prognosis (Bielack
et al., 2002; Meyers et al., 2005, 2008). Therefore, the presence
of pulmonary metastases is typically responsible for OS mortal-
ity (Meyers and Gorlick, 1997). However, little is known about
the biochemical signaling pathways that are critical for the pro-
gression of metastatic disease, and the molecular biology of OS
remains poorly understood. As a result, we have yet to develop any
efficacious drugs that specifically target metastatic disease.
Notch signaling is critical for many cellular processes includ-
ing development and tissue homeostasis. For this reason, Notch
has been called “the stem cell master switch” (Artavanis-Tsakonas
et al., 1999; Lai, 2004). Its role in the formation and progres-
sion of cancer has also been reported (Bray, 2006). Although
a role for Notch signaling in cancer metastasis is evolving, our
current understanding is limited (Hu et al., 2012). The Notch
family of transmembrane receptors is activated when their coun-
terpart transmembrane ligands bind to the extracellular domain
of Notch. This receptor-ligand interaction is mediated by cell–cell
contacts and initiates the cleavage of Notch intracellular domain
(NICD) by the Presenilin family of gamma-secretases. NICD is
then free to translocate to the nucleus and initiate a variety of
genetic programs through the regulation of gene transcription.
Notch signaling is vastly complex and its influence on cellular
processes is highly dependent on cellular context, lineage, com-
mitment, and timing (Bray, 2006). Notch signaling plays a critical
role in cell proliferation, differentiation, and apoptosis. Notch dys-
regulation is felt to be responsible for a variety of human cancers
including leukemia, pancreas, breast, prostate, melanoma, and gas-
trointestinal tract neoplasia (Miyamoto et al., 2003; Weng et al.,
2004; van Es et al., 2005; Bray, 2006; Wang et al., 2010; Hu et al.,
2012). In addition, it was recently discovered that Notch signaling
is activated in human OS and may play a role in tumor invasion
and metastasis (Engin et al., 2008; Zhang et al., 2008, 2010). The
primary goal of this study was to investigate the role of Notch
signaling in OS metastasis.
K7M2 murine OS cells are highly metastatic to the lungs and
were clonally derived from the much less metastatic K12 OS cells
(Khanna et al., 2000). The K7M2 and K12 cell populations are
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related but differ dramatically in their metastatic phenotypes. They
therefore represent excellent tools for determining the critical bio-
chemical pathways in OS metastasis. After comparing these cell
lines in vitro, we report that Notch signaling is up-regulated and
associated with higher aldehyde dehydrogenase 1A1 activity alde-
hyde dehydrogenase (ALDH, a cancer stem cell marker) (Marcato
et al., 2011), increased resistance to oxidative stress, migration,
invasion, and VEGF expression, but is not essential for the pro-
liferation of K7M2 and K12 cells, suggesting that alternative or
compensatory signal transduction pathways may play a role in
OS cell proliferation in this system. These experiments provide
evidence that the Notch pathway is critical for OS metastasis
and may regulate ALDH activity. Notch is thus further impli-
cated as a putative target in the treatment and prevention of OS
metastasis.
MATERIALS AND METHODS
CELL CULTURE AND DAPT TREATMENT
K7M2 cells and K12 cells were cultured with proliferation medium
(PM, DMEM with 10% FBS and 5% penicillin and strepto-
mycin). For Notch inhibition of K7M2 cells, the Notch gamma-
secretase inhibitor DAPT (N -[N -(3,5-difluorophenacetyl)-l-
alanyl]-s-phenylglycine t -butyl ester, from Sigma) was dissolved in
DMSO (10 mM), and diluted 1:1000 in PM to a working concen-
tration of 10µM. K7M2 cells were seeded in 12-well plastic plates
at 5000 cells per well, and 1 mL treatment medium containing
DAPT was added each well. One microliter medium containing
same amount of DMSO without DAPT served as control treat-
ment. Treatment medium was refreshed each day and cells were
treated for 2–4 days.
NOTCH ACTIVATION IN K12 CELLS WITH JAGGED1
K12 cells were treated with active Jagged1 peptide (CDDYYYGFGC-
NKFCRPR) or scrambled peptide (RCGPDCFDNYGRYKYCF)
(GenScript USA, Inc.; 20µg/mL) in PM for 4 days to compare
their various properties. Treatment medium was refreshed each
day. Fluorescence-activated cell sorting (FACS) Analysis of ALDH
Activity. The Alde lfluor Kit (STEMCELL Technologies) was used
in this analysis. Cultured K7M2 cells and K12 cells, with or without
DAPT treatment (10µM for 48 h) were resuspended in Alde-
fluor buffer (1× 106 cells/mL), and incubated at 37° C according
to the manufacturer’s instructions. Cells were washed in Alde-
fluor buffer and maintained in 4° C throughout the analysis
process. ALDH activity was assessed using the FL1 channel of a
BD FACSAria Cell Sorting System and FACSDiva software (ver-
sion 6.1.2; Becton, Dickinson and Company, San Jose, CA, USA).
Collected cells were gated on their fluorescence intensity, which
corresponds to their ALDH activity levels, as well as low side
scatter (SCClo).
FLUORESCENCE-ACTIVATED CELL SORTING BY ALDH ACTIVITY
Cultured K7M2 cells were trypsinized, washed in cold PBS, and
counted using a hemocytometer. Cells (106) of each population
were resuspended in Aldefluor buffer, which contains an ABC
transport inhibitor that prevents efflux of the Aldefluor dye, and
incubated at 37° C according to the manufacturer’s instructions.
Cells were washed in Aldefluor buffer and maintained in 4° C
throughout the cell sorting process. Collected cells were gated on
their fluorescence intensity, which corresponds to their ALDH
activity levels, as well as low side scatter (SCClo). Sorted cells
were recaptured in cold (4° C) PM and immediately plated in
collagen-I coated flasks and normal incubation conditions (5%
CO2 at 37° C).
CELL PROLIFERATION ASSAY
K7M2 and K12 cells were plated at 1000 cells per well in 12-well
plates and cultured in PM. A time-lapsed microscopic live-cell
imaging (LCI) system (Automated Cell, Inc.) was used to take
images of cells per field of view at 15 min intervals for 4 days.
The approximate population doubling time (PDT) as determined
as follows: 2n= cell number at harvest time/cell number initially
plated; “n” refers to the number of doublings during the period of
cell culture (96 h), thus PDT= 96 h/n.
CELL SURVIVAL ASSAY AFTER EXPOSURE TO OXIDATIVE STRESS
To test the role of Notch inactivation on the antioxidant capacity
in K7M2 cells, K7M2 were pre-treated with DAPT (10µM) for
48 h prior to exposure to oxidative stress (0, 250, or 500µM H2O2
in PM) conditions for 6 h. Propidium iodide (PI) was added to
the medium (1µg/mL) and apoptotic cells were identified with
positive PI staining.
CELL MIGRATION STUDY WITH IN VITRO WOUND REPAIR ASSAY
K7M2 cells with or without treatment with DAPT (10µM for
48 h) were grown to near confluence in a 12-well multi-well plate.
Artificial wounds were created by disrupting cell monolayers with
a sterile pipette-tip. Cellular debris was aspirated and fresh PM
was added to the wells. Images of cell migration into the arti-
ficial wound were taken at 0 and 9 h after creating the artificial
wound as previously described (Mu et al., 2010). Cell migra-
tion was measured in microns (µm) by the distance traveled into
wound site.
CELL MIGRATION STUDY WITH IN VITRO INVASION ASSAY
In vitro invasion capacity of K7M2 and K12 cells was assessed using
a real-time cell invasion and migration (RT-CIM) assay system
(ACEA Biosciences, Inc.), with a 16-well trans-well plate (CIM-
plate 16, Roche Diagnostics GmbH). The surface of the wells in
the upper chamber was coated with Matrigel (BD BioSciences,
Bedford, MA, USA) of different concentrations (2.5, 5, and 10%).
Serum-containing medium (10% FBS) was added to the wells of
the lower chamber. Cells (4× 104 per well) in serum-free medium
were seeded in the upper chamber. The migration of the cells
through the Matrigel was monitored by the system every 15 min
for 18 h. Data analysis was carried out using RTCA Software 1.2
supplied with the instrument.
REVERSE TRANSCRIPTION-PCR
Total RNA was extracted from the cells using the RNeasy plus mini
kit (Qiagen) and cDNA was generated using the iScript cDNA
Synthesis kit (Bio-Rad). The sense and anti-sense primers for
reverse transcription polymerase chain reaction (RT-PCR) and
their product sizes are found in the Table 1. The cycling parame-
ters used for all reactions were as follows: 94° C for 5 min; 30 cycles
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Table 1 | Primer sequences.
Gene Primer sequence
GAPDH Forward: TCCATGACAACTTTGGCATTG
Reverse: TCACGCCACAGCTTTCCA
Notch1 Forward: GCCGCAAGAGGCTTGAGAT
Reverse: GGAGTCCTGGCATCGTTGG
Notch2 Forward: GAGAAAAACCGCTGTCAGAATGG
Reverse: GGTGGAGTATTGGCAGTCCTC
Notch3 Forward: TGCCAGAGTTCAGTGGTGG
Reverse: CACAGGCAAATCGGCCATC
Notch4 Forward: CCAGAATGCGAGACAGAACTG
Reverse: GGTCAACCCCATGTAGCCTG
Hes1 Forward: CCAGCCAGTGTCAACACGA
Reverse: AATGCCGGGAGCTATCTTTCT
Stat3 Forward: CAATACCATTGACCTGCCGAT
Reverse: GAGCGACTCAAACTGCCCT
c-Myc Forward: TGACCTAACTCGAGGAGGAGCTGGAATC
Reverse: AAGTTTGAGGCAGTTAAAATTATGGCTGAAGC
BMP2 Forward: TCTTCCGGGAACAGATACAGG
Reverse: TGGTGTCCAATAGTCTGGTCA
BMP4 Forward: ATTCCTGGTAACCGAATGCTG
Reverse: CCGGTCTCAGGTATCAAACTAGC
VEGF Forward: GCCAGACAGGGTTGCCATAC
Reverse: GGAGTGGGATGGATGATGTCAG
ALDH Forward: GACAGGCTTTCCAGATTGGCTC
Reverse: AAGACTTTCCCACCATTGAGTGC
of the following: denature for 45 s at 95° C, anneal for 30 s (53–56°
C), and extend for 45 s at 72° C. RT-PCR was performed using a
Bio-Rad MyiQ thermal cycler (Bio-Rad).
MEASUREMENT OF RESULTS AND STATISTICAL ANALYSIS
Reverse transcription-polymerase chain reaction analysis was per-
formed using ImageJ software (version 1.32j, National Institutes of
Health, Bethesda, MD, USA) where the integrated density (prod-
uct of the area and the mean gray value) of bands was calculated.
All molecular bands were represented as a percentage of a standard
gene, GAPDH. At least three samples obtained from each subject
were pooled for statistical analysis of all results from this study,
and the results are expressed as a mean± SD. The differences
between two means were considered to be statistically signifi-
cant if P value is <0.05. A student’s t -test was used to determine
whether there were statistically significant differences between two
means.
RESULTS
NOTCH SIGNALING IS UP-REGULATED IN K7M2 CELLS
In order to investigate the role of Notch signaling in OS metastasis
we first performed RT-PCR to analyze the expression of Notch
genes, and their canonical downstream target genes, Hes1 and
Stat3, in K7M2 and K12 cells (Kamakura et al., 2004; Borggrefe
and Oswald, 2009). Using this system we have previously shown
that Bmp2 and VEGF expression are up-regulated in K7M2 cells
compared to K12 cells (Weiss et al., 2006). Therefore, we included
Bmp2 and VEGF as historical controls in addition to the load-
ing control, GAPDH. We observed a significant up-regulation of
almost twofold in each of Notch-1, -2, and -4 transcripts, with
concomitant up-regulation of the Notch target genes, Hes1 and
Stat3, in K7M2 cells compared to K12 cells (Figure 1). Inter-
estingly, Notch3 expression was significantly down-regulated in
K7M2 cells compared to K12 cells. Likewise, and somewhat sur-
prisingly, c-Myc expression, a proto-oncogene known to be posi-
tively regulated by Notch signaling (Klinakis et al., 2006), was also
significantly down-regulated in K7M2 cells.
Aldehyde dehydrogenase activity is found in a variety of human
cancers and has been associated with metastasis, drug resistance,
and poor prognosis (Cheung et al., 2007; Cho et al., 2007; Huang
et al., 2009; Charafe-Jauffret et al., 2010; Honoki et al., 2010). Here
we observed a twofold up-regulation of ALDH gene transcript
levels in K7M2 cells (Figure 1). In our previous study we have
performed FACS analysis to quantitate the percentage of cells with
ALDH activity in K7M2 and K12 cells (Mu et al., 2012). Consistent
with our RT-PCR results, we observed a threefold increase in the
percentage of K7M2 cells with high ALDH activity compared to
K12 cells.
In order to investigate the relationship between Notch acti-
vation and ALDH activity in the highly metastatic K7M2 cells
we inhibited Notch signaling with the gamma-secretase inhibitor,
DAPT (Geling et al., 2002). We then performed RT-PCR to con-
firm the inhibition of Notch activity. Figure 2A shows a signif-
icant reduction in Notch1, -2, -4, and Hes1 gene expression in
K7M2 cells after culture in DAPT-conditioned medium, whereas,
we did not observe a significant alteration in Notch3, c-Myc,
or Bmp4 transcript levels after exposure to DAPT. Interestingly,
the expression of ALDH was significantly down-regulated after
DAPT treatment, as was Bmp2 and VEGF expression. In order
to further investigate ALDH activity in the setting of Notch inhi-
bition, we utilized FACS and observed a near twofold reduction
in cells positive for ALDH activity (12.2± 2.1 vs. 23.1± 3.5%,
P < 0.05) after treatment with DAPT (Figure 2B). After con-
firming that DAPT reduces Notch signaling, ALDH expression,
and ALDH activity in K7M2 cells, we wanted to investigate the
effects of DAPT treatment on K7M2 cell proliferation, resis-
tance to oxidative stress, migration, and invasion in vitro as
these are phenotypes that confer metastatic potential (Hu et al.,
2012).
NOTCH INHIBITION SENSITIZES K7M2 CELLS TO OXIDATIVE STRESS
BUT DOES NOT ALTER PROLIFERATION
First, we analyzed K7M2 cell proliferation with and without
DAPT treatment. After 4 days of culture, we did not observe a
change in cell density as illustrated by the representative images
in Figure 3A, and there was no significant change in cell popu-
lation growth between K7M2 cells treated with or without DAPT
(Figure 3B).
Next, we tested resistance to oxidative stress using H2O2 treat-
ment. Apoptosis was monitored by nuclear inclusion of PI. In our
previous study we have shown that after treatment with H2O2,
the large majority (>85%) of K12 cells underwent apoptosis as
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FIGURE 1 | Notch activation and ALDH activity in K7M2 cells.
RT-PCR was performed on cellular RNA extracted from K7M2 and K12
cells in order to quantitate the relative expression of Notch genes 1, 2,
3, 4, and canonical downstream targets of notch, Hes1, STAT3, and
C-myc. In addition, ALDH gene expression was compared between
K7M2 and K12 cells. BMP2 and BMP4 were included as positive and
negative controls. GAPDH serves as a loading control for both lanes.
The RT-PCR results were quantitated and the results are displayed in
graph representation. Gene expression was normalized using GAPDH.
The ratio of K7M2 gene expression to K12 gene expression is shown.
*Indicates the difference is significant comparing DAPT treated or
non-treated samples (P <0.05).
FIGURE 2 | Notch inhibition with DAPT reduces Notch signaling and
BMP2,VEGF, and ALDH expression in K7M2 cells. (A) RT-PCR was
performed on cellular RNA extracted from K7M2 cells treated with DAPT
or vehicle only (control) in order to quantitate the relative expression of
Notch genes, and Notch targets Hes1 and C-myc. In addition, BMP2,
VEGF, and ALDH gene expression was compared between DAPT-treated,
and untreated, K7M2 cells. GAPDH serves as a loading control for both
lanes. The RT-PCR results were quantitated and the results are displayed
in graph representation. Gene expression was normalized using GAPDH.
(B) ALDH activity was detected in DAPT-treated and untreated K7M2
cells using flow cytometric analysis and the relative amount of cells
positive for ALDH is shown for each cell population. *Indicates the
difference is significant comparing DAPT-treated or non-treated samples
(P <0.05).
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FIGURE 3 | Notch inhibition with DAPT does not affect proliferation of
K7M2 cells. (A) K7M2 cells were cultured with media containing 10µM DAPT
or vehicle only (control) for 4 days. Representative images of cell density at
the beginning and end of treatment are shown. Similar number of cells was
observed between the two groups. (B)The population doubling time of K7M2
cells with or without DAPT treatment showed no significant difference.
indicated by PI inclusion, whereas most of the K7M2 cells main-
tained viability (>65%) as indicated by nuclear exclusion of PI
(Mu et al., 2012). Therefore, K7M2 cells are more resistant to
oxidative stress from H2O2 exposure than K12 cells. In order to
test if this resistance to H2O2 was related to Notch or ALDH activ-
ity we repeated these experiments on K7M2 cells in the presence or
absence of DAPT and 0, 250, or 500µM of H2O2. Representative
images are shown in Figure 4. We observed a dose-dependent sen-
sitivity to H2O2 with DAPT treatment as DAPT caused a twofold
increase in apoptosis at 250µM H2O2, and greater than a four-
fold increase in apoptosis at 500µM H2O2. DAPT alone is not
pro-apoptotic in this assay, as DAPT in the absence of H2O2
did not increase the frequency of PI nuclear inclusion in K7M2
cells.
NOTCH INHIBITION REDUCES K7M2 CELL MIGRATION AND INVASION
IN VITRO
As mentioned, K7M2 cells are much more metastatic than K12
cells (Khanna et al., 2000). Consistent with this enhanced metasta-
tic potential, we performed in vitro migration and invasion assays
in our previous study and observed K7M2 cells to migrate and
invade significantly faster than K12 cells (Mu et al., 2012). Here
we tested the effect of DAPT treatment on the ability of K7M2
cells to perform in these migration and invasion assays. Figure 5A
is a representative image depicting the migration front of K7M2
cells after 9 h of treatment with and without DAPT. We observed
a significant reduction in K7M2 cell migration distance after 9 h
of DAPT treatment when compared to control (Figure 5B). Simi-
larly, we observed a significant reduction in cell index achieved by
K7M2 cells in an invasion assay through 2.5, 5, and 10% Matrigel
after 18 h of DAPT treatment (Figure 5C). In our assays, K12 cells
did not invade the 10% Matrigel effectively and this was unaffected
by the presence of DAPT.
ACTIVATION BUT NOT INACTIVATION OF NOTCH SIGNALING IN K12
CELLS INCREASED THE METASTATIC PROPERTIES
To further verify the involvement of Notch signaling in regulating
metastatic properties of OS cells, K12 cells expressing lower level
FIGURE 4 | K7M2 cells are resistant to treatment with H2O2 but
become sensitive in the presence of DAPT. (A) K7M2 cells were treated
with or without DAPT (10µM) for 4 days, and were then cultured with
media containing H2O2 (0, 250, or 500µM) for 6 h and cell death was
analyzed using PI exclusion assay. Representative images are shown. (B)
The percentage of PI+ cells was determined for each group in (A).
*Indicates the difference is significant comparing DAPT-treated or
non-treated samples (P <0.05).
of Notch genes were treated with DAPT and a Notch activating
ligand, Jagged1. Results revealed that neither DAPT nor Jagged1
treatment had an obvious effect on the proliferation of K12 cells
(Figures 6A,B), but Jagged1 treatment specifically increased the
anti-oxidative stress capacity of the cells (Figures 6C,D). Also, the
in vitro invasion capacity of K12 cells was increased by Jagged1
treatment for 4 days (Figure 6E). Moreover, the expression of
Notch1, Hes1, and ALDH1A1 was found to be up-regulated with
Jagged1 treatment of K12 cells (Figure 6F).
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FIGURE 5 | K7M2 cells have greater migratory capacity and this is
inhibited by DAPT treatment. (A) Migratory ability of untreated K7M2 cells
and DAPT-treated K7M2 cells was analyzed by cell migration study with
in vitro wound repair assay, and representative images are shown. (B)The
speed of migration was determined in each group in (A) and the results are
displayed. (C) DAPT treatment resulted in decreased in vitro invasion capacity
of K7M2 cells in 2.5, 5, or 10% matrigel. *Indicates the difference is
significant comparing DAPT-treated or non-treated samples (P <0.05).
SORTED ALDH-HIGH AND ALDH-LOW K7M2 CELLS FEATURE
DIFFERENTIAL NOTCH EXPRESSION AND ANTI-OXIDATIVE STRESS
CAPACITY
We have previously sorted K7M2 cells according to ALDH activ-
ity (Figure 7A) (Mu et al., 2012), and found ALDH-high cells
demonstrated stronger in vitro invasion capacity than ALDH-low
cells. Here, to further verify the involvement of Notch signaling
in regulating ALDH activity, we have compared the expression
of Notch genes in the two types of cells, and found up-regulated
expression of Notch1, Hes1, and ALDH1A1 genes in ALDH-high
K7M2 cells (Figure 7B). Also, the anti-oxidative stress capacity of
ALDH-high cells was found much higher than that of ALDH-low
cells (Figure 7C). These observations further implicated there is
potential interaction between Notch signaling with ALDH in our
system.
DISCUSSION
K7M2 murine OS cells are highly metastatic to the lungs and
were clonally derived from the much less metastatic K12 OS cells
(Khanna et al., 2000). Thus, the K7M2 and K12 cell lines are similar
but differ drastically in their metastatic phenotypes, and therefore
represent an excellent tool for determining critical biochemical
pathways in OS metastasis. Here we report that the Notch genes
(1, 2, and 4) are highly expressed, including downstream targets
Hes1 and Stat3, indicating that the Notch signaling pathway is
more active in K7M2 cells. These results imply that Notch signaling
may contribute to the enhanced metastatic ability of K7M2 cells.
To support this interpretation we have provided in vitro evidence
illustrating that Notch activity is associated with many cellular
behaviors important for metastasis. Notch inhibition via DAPT
treatment also reduces ALDH activity and inhibits resistance to
oxidative stress, cellular migration, invasion, and VEGF expres-
sion (a strong promoter of angiogenesis) (Witzenbichler et al.,
1998; Zhang et al., 2000); all key cellular processes that required
for metastatic progression (Hu et al., 2012).
A role for Notch signaling in OS metastasis is supported in
the work published by Zhang et al. (2008) who found Notch1,
Notch2, DLL1, and Hes1 over-expression in a number of human
OS tumor samples and cell lines, and observed that compound
E (a gamma-secretase inhibitor) reduced Matrigel invasion by
these OS cells. The authors also implicated Notch signaling in
OS metastasis by showing that expression of dominant neg-
ative Mastermind was able to block OS187 metastasis in a
xenograft model. More recently the same group provided evi-
dence that reciprocal inhibition of two downstream targets of
Notch, Hes1, and Deltex1, may be the transcriptional control
mechanisms that regulate cellular invasiveness in OS (Zhang et al.,
2010).
Aldehyde dehydrogenase activity has been identified as a “can-
cer stem cell” (CSC) marker in numerous neoplasia. ALDH has
been associated with metastasis and poor prognosis but such a
role has yet to be established in OS (Cheung et al., 2007; Cho
et al., 2007; Huang et al., 2009; Charafe-Jauffret et al., 2010;
Honoki et al., 2010). The CSC hypothesis predicts that if cer-
tain genetic alterations occur in the right context, and within
a more primitive cell, then a cancer initiating cell is born that
retains all the qualities of stem cells including, self renewal, prolif-
eration, differentiation, resistance to drugs, stress, and apoptosis,
and perhaps most importantly, the ability to migrate, invade, and
induce angiogenesis (Wicha et al., 2006). Although the relation-
ship between CSCs and metastasis has not been clearly elucidated,
it has been demonstrated that the number of metastatic cancer
colonies correlates with the frequency of CSCs in the primary tis-
sue. Furthermore, CSC subpopulations display a higher potential
for invasiveness than subpopulations of non-stem tumor cells (Hu
et al., 2012).
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FIGURE 6 | Inhibition and activation of Notch signaling in K12 cells
with DAPT and Jagged1. (A) DAPT or Jagged1 treatment of K12 cells
showed no effect on cell proliferation. (B) Statistics of population doubling
time (PDT) with or without treatment. (C) Jagged1 treatment, but not
DAPT treatment of K12 cells resulted in reduced cell apoptosis induced by
H2O2 (250µM; PI staining). (D) Statistics of PI+ cells with or without
treatment. (E) Jagged1 treatment of K12 cells increased the in vitro
invasion capacity of the cells through 2.5% matrigel. (F) RT-PCR showed
that the expression of Notch1, Hes1, and ALDH1A1 was up-regulated in
K12 cells with Jagged1 treatment.
In terms of stem cell regulation, Notch is important for self
renewal, proliferation, and maintenance of progenitor cells (Bray,
2006). Interestingly, altered Notch1 signaling alone in a T cell prog-
enitor causes T cell acute lymphoblastic leukemia suggesting that
Notch1 dysregulation may be a critical event for the CSC in this
malignancy (Weng et al., 2004). Although an OS stem cell has
not been identified to date, evidence suggests that this discovery
is merely a matter of time (Gibbs et al., 2011). Notch signaling
indeed has the potential to regulate an OS stem cell as recent
genetic evidence links Notch activity to osteoblast differentia-
tion, proliferation, and lineage commitment. This demonstrates
that Notch plays a key role in osteoprogenitor cell maintenance
and bone homeostasis (Engin et al., 2008; Hilton et al., 2008). If
an OS stem cell exists, we suspect that both Notch and ALDH
activity play pivotal roles in the maintenance of this subpopu-
lation of cancer cells. ALDH activity may prove to be a useful
marker to identify the cells within a tumor that have OS stem cell
characteristics.
In this study, we observed that K7M2 cells exhibit higher lev-
els of ALDH activity and this is dependent on Notch signaling
as indicated by treatment with a gamma-secretase inhibitor. Fur-
thermore, we showed that K7M2 cells, in comparison to K12
cells, are more resistant to oxidative stress induced by H2O2
treatment. Treating less metastatic K12 cells with the Notch acti-
vator Jagged1 increased the resistance of these cells to oxidative
stress, enhanced their invasiveness, and altered their expression
of Notch1, Hes1, and ALDH. It did not alter their proliferation.
The activity of ALDH in cancer may function to neutralize oxida-
tive stress and provide chemoresistance. Up-regulation of ALDH
activity by Notch may be the mechanism that confers resistance
to oxidative stress in K7M2 cells (Russo and Hilton, 1988; Magni
et al., 1996). Alternatively, disulfiram, an ALDH inhibitor, has been
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FIGURE 7 | Sorted ALDH-high andALDH-low K7M2 cells show different
expression patterns and resistance to oxidative stress. (A) Demonstration
of the strategy for sorting of ALDH-high and ALDH-low cells. (B) ALDH-high
cells featured higher expression of Notch1, Hes1, and ALDH1A1, compared
to ALDH-low cells. (C) ALDH-high cells demonstrated reduced cell apoptosis
induced by H2O2 (250µM; PI staining), compared to ALDH-low cells.
shown to reduce the invasiveness of U2OS cells, and the expression
of matrix metalloproteinases, raising the possibility that ALDH
activity may have a more direct role in tumor invasion (Cho et al.,
2007). We have shown recently that disulfiram reduces ALDH
activity in K7M2 cells, and is associated with morphologic changes
as well (Mu et al., 2012). However, the mechanism for disulfiram’s
effect on OS cell invasion remains unclear.
It is somewhat surprising that DAPT did not significantly alter
the proliferation of K7M2or K12 cells because Notch signaling is
known to be pro-proliferative. We do believe this speaks to the
complexity of Notch signaling and illustrates that the outcome
of Notch activity depends on the cellular context and is probably
influenced by many factors. In terms of the regulation of cellu-
lar proliferation, transcriptional activation of the proto-oncogene
c-Myc by NICD can promote S-phase entry through the up-
regulation of cyclins and the down-regulation of cyclin-dependent
kinase inhibitors (Klinakis et al., 2006). The molecular result is the
inactivation of the retinoblastoma protein (pRB) by phosphory-
lation which allows for transcription of E2F genes necessary for
the cell cycle to advance through G1 (van den Heuvel and Dyson,
2008). In OS, pRB is frequently inactivated by direct mutation
(Wang, 2005; Hayden and Hoang, 2006), and thus, c-Myc expres-
sion may not be necessary in this context for cell proliferation.
This may explain why down-regulation of c-Myc in K7M2 cells
does not cause growth arrest. Furthermore, inhibition of Notch
signaling may have no effect on proliferation in K7M2 or K12 cells
simply because pRB may be inactivated by another mechanism,
and thus is essentially uncoupled from Notch activity.
CONCLUSION
Notch signaling is important in many cancers and has been iden-
tified as both a tumor suppressor and an oncogene, illustrating
the inherent complexity of this signaling pathway (Radtke and
Raj, 2003; Weng et al., 2004; Bray, 2006). Our work supports an
oncogenic role for Notch in OS and provides evidence to link
Notch signaling, ALDH activity, and metastatic potential. To our
knowledge the present study is the first to implicate Notch in the
regulation of ALDH activity. Given our data and other evidence
that implicates Notch and ALDH function in CSCs, we suspect
that if an OS cancer stem cell (OSC) exists, Notch and ALDH may
be important for OSC maintenance, drug resistance, and metas-
tasis, and ALDH may be a potential OSC surface marker. At this
point in time we cannot be certain that ALDH is downstream of
Notch. These and other ideas regarding the relationships between
Notch, ALDH, and the putative OSC require further investigation.
In conclusion, Notch signaling is up-regulated and associated
with increased ALDH expression, ALDH activity, resistance to
oxidative stress, migration, invasion, and VEGF expression in vitro.
It is not essential for growth, suggesting that alternative or com-
pensatory signal transduction pathways may play a role in OS cell
proliferation. This work implicates Notch as a putative target in
the treatment and prevention of OS metastasis.
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